Piriprost

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 585339

CAS#: 79672-88-1 (free base)

Description: Piriprost is a leukotriene inhibitor attenuates the smoke-induced increase in alveolar-capillary barrier permeability and decrease in plasminogen activator activity and causes a swelling of type I alveolar epithelium.

Chemical Structure

img
Piriprost
CAS# 79672-88-1 (free base)
Instruction

Theoretical Analysis

MedKoo Cat#: 585339
Name: Piriprost
CAS#: 79672-88-1 (free base)
Chemical Formula: C26H35NO4
Exact Mass: 425.26
Molecular Weight: 425.569
Elemental Analysis: C, 73.38; H, 8.29; N, 3.29; O, 15.04

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 88851-62-1 (K); 79672-88-1 (free base)  

Synonym: Piriprost; U-60,257; U60,257; U 60,257

IUPAC/Chemical Name: 5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-1-phenyl-5,6-dihydro-4H-cyclopenta[b]pyrrol-2-yl]pentanoic acid

InChi Key: CZIIGGQJILPHEU-HCHVXQBBSA-N

InChi Code: InChI=1S/C26H35NO4/c1-2-3-5-13-21(28)15-16-22-23-17-20(12-8-9-14-26(30)31)27(24(23)18-25(22)29)19-10-6-4-7-11-19/h4,6-7,10-11,15-17,21-22,25,28-29H,2-3,5,8-9,12-14,18H2,1H3,(H,30,31)/b16-15+/t21-,22+,25+/m0/s1

SMILES Code: O=C(O)CCCCC1=CC([C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C2)=C2N1C3=CC=CC=C3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 425.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Tew KD, Bomber AM, Hoffman SJ. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 1988 Jul 1;48(13):3622-5. PubMed PMID: 3288331.

2: Mann JS, Robinson C, Sheridan AQ, Clement P, Bach MK, Holgate ST. Effect of inhaled piriprost (U-60, 257) a novel leukotriene inhibitor, on allergen and exercise induced bronchoconstriction in asthma. Thorax. 1986 Oct;41(10):746-52. PubMed PMID: 3538476; PubMed Central PMCID: PMC460468.

3: Cejic SS, Kennedy TG. Examination of the effects of piriprost (U-60,257B) on alkaline phosphatase activity of rat endometrial stromal cells in vitro. Prostaglandins. 1991 Aug;42(2):179-89. PubMed PMID: 1775638.

4: Witten ML, Grad R, Quan SF, Sobonya RE, Hubbard AK, Lantz RC, Lentz LA, Devine LC, Lemen RJ. Piriprost pretreatment attenuates the smoke-induced increase in 99mTcDTPA lung clearance. Exp Lung Res. 1990 Jul-Aug;16(4):339-53. PubMed PMID: 2118452.

5: Johnson HG, Stout BK, Ruppel PL. Inhibition of the 5-lipoxygenase pathway with piriprost (U-60,257) protects normal primates from ozone-induced methacholine hyperresponsive small airways. Prostaglandins. 1988 Mar;35(3):459-66. PubMed PMID: 3287458.

6: Cejic SS, Kennedy TG. Effects of piriprost (U-60, 257B) and leukotrienes on alkaline phosphatase activity of rat endometrial stromal cells in vitro. Prostaglandins. 1991 Aug;42(2):163-79. PubMed PMID: 1663640.

7: Bach MK, Brashler JR. Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor. Biochem Pharmacol. 1986 Feb 1;35(3):425-33. PubMed PMID: 3004501.

8: Bach MK, Brashler JR, White GJ, Galli SJ. Experiments on the mode of action of piriprost (U-60,257), an inhibitor of leukotriene formation in cloned mouse mast cells and in rat basophil leukemia cells. Biochem Pharmacol. 1987 May 1;36(9):1461-6. PubMed PMID: 3107573.

9: Bach MK, O'Brien J, Brashler JR, Johnson MA, Morton DR Jr. Inhibition of rat liver glutathione S-transferases by piriprost: kinetics of the inhibition and preliminary evidence that piriprost may be a poor alternative substrate for these enzymes. Res Commun Chem Pathol Pharmacol. 1985 Sep;49(3):361-86. PubMed PMID: 3903894.

10: Flament J, Schandene L, Boeynaems JM. Effect of the 5-lipoxygenase inhibitor piriprost on superoxide production by human neutrophils. Prostaglandins Leukot Essent Fatty Acids. 1988 Dec;34(3):175-80. PubMed PMID: 2851839.

11: Mehta JL, Mehta P, Ward MB, Lawson D. Inhibition of human platelet and neutrophil function by piriprost (U-60,257). Prostaglandins Leukot Med. 1987 Oct;29(2-3):259-67. PubMed PMID: 3124134.

12: Keane WF, Gekker G, Schlievert PM, Peterson PK. Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am J Pathol. 1986 Jan;122(1):169-76. PubMed PMID: 3079956; PubMed Central PMCID: PMC1888123.

13: Arenas G, Del Buono R, Oyarzún MJ, Donoso P, Quijada D. Pulmonary response to free fatty acid intravenous infusion in the rabbit: role of leukotrienes and the effect of prostacyclin. Arch Biol Med Exp (Santiago). 1989 Dec;22(4):379-85. PubMed PMID: 2488536.

14: Lawson CF, Smith HW, Fitzpatrick FA. Effect of Piriprost, a 5-lipoxygenase inhibitor, on leukocyte accumulation during thioglycollate-induced acute inflammation. Wien Klin Wochenschr. 1986 Feb 21;98(4):110-3. PubMed PMID: 3085355.

15: Bach MK, Griffin RL, Richards IM. Inhibition of the presumably leukotriene-dependent component of antigen-induced bronchoconstriction in the guinea pig by piriprost (U-60,257). Int Arch Allergy Appl Immunol. 1985;77(1-2):264-6. PubMed PMID: 3924840.

16: Lebidois J, Soifer SJ, Clyman RI, Heymann MA. Piriprost: a putative leukotriene synthesis inhibitor increases pulmonary blood flow in fetal lambs. Pediatr Res. 1987 Sep;22(3):350-4. PubMed PMID: 3309861.

17: Snider BG, Theis DL, Plaisted SM. Stability studies on piriprost and piriprost potassium using high-performance liquid chromatography. J Chromatogr. 1986 Sep 26;367(1):254-9. PubMed PMID: 3536978.

18: Bach MK, Bowman BJ, Brashler JR, Fitzpatrick FA, Griffin RL, Johnson HG, Major NJ, McGuire JC, McNee ML, Richards IM, et al. Piriprost: a selective inhibitor of leukotriene synthesis. Adv Prostaglandin Thromboxane Leukot Res. 1985;15:225-7. PubMed PMID: 2936098.

19: Burka JF. Pharmacological modulation of responses of guinea-pig airways contracted with antigen and calcium ionophore A23187. Br J Pharmacol. 1985 Jun;85(2):411-20. PubMed PMID: 3928008; PubMed Central PMCID: PMC1916616.

20: Smith RJ, Bowman BJ, Speziale SC. Interleukin-1 stimulates granule exocytosis from human neutrophils. Int J Immunopharmacol. 1986;8(1):33-40. PubMed PMID: 2420732.